Increasing the cyclodextrin complexation of drugs and drug bioavailability through addition of water-soluble polymers

被引:0
作者
Loftsson, T [1 ]
机构
[1] Univ Iceland, Dept Pharm, IS-127 Reykjavik, Iceland
来源
PHARMAZIE | 1998年 / 53卷 / 11期
关键词
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
For a variety of reasons, including cost, production capabilities and toxicology, the amounts of cyclodextrin (CD) that can be included in drug formulations is limited and, thus, it is important to develop methods which can be applied to enhance the complexation efficacy. Moreover, bioavailability of drugs in CD containing vehicles can be rather limited resulting in less than optimal drug delivery. Addition of small amounts of a water-soluble polymer to the aqueous complexation media enhances the CD complexation of drugs. Thus, less CD is needed to dissolve a given amount of drug when a polymer is present than when it is not present in the aqueous complexation media. Furthermore, the bioavailability of drugs is enhanced through addition of polymers. In general, the water-soluble polymers improve both pharmaceutical and biological properties of drug-CD complexes. This polymer enhancement of drug complexation and bioavailability is independent of the physicochemical properties of the drug. Thermodynamic studies and other physicochemical observations indicate that the polymers participate directly in the drug-CD complexation.
引用
收藏
页码:733 / 740
页数:8
相关论文
共 44 条
  • [1] ATTWOOD D, 1983, SURFACTANT SYSTEMS T, P361
  • [2] BJORNSDOTTIR B, 1997, THESIS U ICELAND REY
  • [3] CARLSON A, 1992, INT PATENT APPL
  • [4] FRIORIKSDOTTIR H, 1996, PHARMAZIE, V51, P39
  • [5] FRIORIKSDOTTIR H, 1997, J CONTROL RELEASE, V44, P95
  • [6] FROMMING KH, 1994, CYCLODEXTRINS PHARM, V5, P224
  • [7] Thermally switchable polyrotaxane as a model of stimuli-responsive supramolecules for nano-scale devices
    Fujita, H
    Ooya, T
    Kurisawa, M
    Mori, H
    Terano, M
    Yui, N
    [J]. MACROMOLECULAR RAPID COMMUNICATIONS, 1996, 17 (08) : 509 - 515
  • [8] Ganzerli G, 1996, PHARMAZIE, V51, P357
  • [9] HLADON T, 1994, PHARMAZIE, V49, P497
  • [10] Pharmaceutical applications of cyclodextrins .3. Toxicological issues and safety evaluation
    Irie, T
    Uekama, K
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (02) : 147 - 162